Swiss HLG 2018 Summer Conference – was an excellent illustration of how two associations collaborate towards a SUCCESSFUL event!
Both Swiss HLG and PCLF invited speakers from both countries to share with the audience their successes and above all how partnering influenced success.
Once again, attendance was a real success with around 130 delegates from Switzerland, France, Germany and other European countries.
The conference started with an insightful introduction from Patrick Aebischer, President emeritus, Brain Mind Institute at EPFL, on critical components and factors to build a successful innovation ecosystem between universities, research institutes, tech transfer offices, accelerator, and entrepreneurship.
Following the opening keynote, we had a series of inspiring presentations held by Jurgi Camblong (CEO of SOPHiAGENETICS), Mondher Majoubi (CEO of Innate Pharma), Hervé Affagard (CEO MaaT Pharma), Andreas Emmenegger (CFO of Molecular Partners). Beyond great insights on their promising technologies, participants could learn how they embraced partnering as a cornerstone strategy for the development of their company.
The event closed after a great panel moderated by Marc Ceulemans (Head of Strategic Investment from Novartis), with Michele Ollier (Partner atMedixci), Christoph Kausch (Partner at MTIP), Jean-Philippe Tripet (Partner at Aravis) and Marie Petit (Principal at Villiger Valuation) which touched on various topics such as cultural differences when building and financing start-ups between Europe and the US; key success factors for a start-up, and financing challenges in some countries.
Last but not least, for the first time, we interviewed some of our speakers, and we will be pleased to share their insights very soon.
Please find below some images from the conference. (Please click on the image to view it in its entirety and or a slide show.)